Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the synergistic effect of coenzyme Q10 on contrast nephropathy
IRCT20220921056012N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of coenzyme q10 in contrast-induced nephropathy (CIN) and chronic kidney disease (CKD), sponsored by Guilan University of Medical Sciences. Started Oct 2022; status: completed.
02
Drugs
coenzyme q10
03
Conditions
contrast-induced nephropathy (CIN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20220921056012N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220921056012N1.